Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor

(Massachusetts General Hospital) Massachusetts General Hospital investigators report the first successful use of a targeted therapy to treat a patient with BRAF-mutant craniopharyngioma, a debilitating, recurrent brain tumor.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news